Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: An atypical case

被引:13
|
作者
Girard, C. [1 ]
Vincent, T. [2 ]
Bessis, D. [1 ]
机构
[1] Univ Montpellier I, CHU, Hop St Eloi, Dept Dermatol, F-34295 Montpellier 5, France
[2] Univ Montpellier I, CHU, Hop St Eloi, Immunol Lab, F-34295 Montpellier 5, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2013年 / 140卷 / 10期
关键词
Dermatomyositis; MDA-5; antibodies; Interstitial lung disease; Acquired ichthyosis; JAPANESE PATIENTS; GENE; 5; JUVENILE DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; AUTOANTIBODIES; CALCINOSIS; ANTI-MDA5; CADM-140; FEATURES; PROTEIN;
D O I
10.1016/j.annder.2013.04.083
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - A new antibody known as anti-MDA-5 has recently been identified in association with a specific phenotype of dermatomyositis (DM), in which muscular involvement is minimal or absent, but where there is a particularly high risk of onset of aggressive interstitial lung disease. Below, we report a case associated with the presence of anti-MDA-5 antibodies complicated by aggressive interstitial lung disease; the cutaneous phenotype of this patient is novel due to the constitution of diffuse ichthyosis and of profuse subcutaneous calcinosis. Patients and methods. - A 35-year-old man was hospitalised for a skin rash associated with arthralgia, dry cough, asthenia and weight-loss of 8 kg in 5 months. The dermatological examination revealed purple erythema of the upper eyelids and cheeks, diffuse acquired ichthyosis of the trunk and limbs, and striated erythema on the proximal and distal metacarpal and interphalangeal joints of the fingers. A diagnosis of DM was suspected in patients treated with prednisolone, 1.5 mg/kg/d. Immunological tests identified the presence of anti-MDA-5 antibodies. One month later, the cutaneous signs continued to progress and were marked by the development of painful ulcers on the back of the fingers, as well as dyspnoea accompanying the slightest effort. Chest images showed constituted pulmonary fibrosis lesions. At the same time, within several months, diffuse, pseudo-tumoural calcifications developed in the subcutaneous tissue of the trunk and limbs. The patient was treated successively with intravenous gammaglobulins, cyclophosphamide, mycophenolate mofetil, azathioprine and rituximab in combination with oral corticosteroids, but with no improvement in respiratory function or in the skin lesions. Because of the decline in the patient's respiratory status, a lung graft was envisaged but subsequently abandoned because of the patient's excessively precarious state of health. Discussion. - Anti-MDA-5 antibody appears to constitute a specific immunological marker for a special dermatological phenotype of adult DM, significantly associated with the presence of: 1) keratotic papules in the skin folds of the palms and fingers; 2) cutaneous ulcers along the periungueal edges, Gottron's papules on the back of the hands and on the extensor surface of the elbows and knees; 3) pain and ulceration in the oral mucosa, diffuse alopecia, and appearance of "mechanic's hands" and Gottron's sign on the elbows and knees. To our knowledge, the presence of extensive ichthyosis and profuse subcutaneous calcinosis has not been previously reported in this particular form of DM. The risk of aggressive interstitial lung disease is particularly high and worsens the prognosis, since 40% of patients with anti-MDA-5 die, usually within the first year. Conclusion. Herein, we describe a patient presenting amyopathic DM complicated by aggressive interstitial lung disease associated with the presence of anti-MDA-5 antibodies, but with a hitherto unreported cutaneous phenotype combining diffuse ichthyosis and profuse subcutaneous calcinosis. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [21] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wanlong Wu
    Li Guo
    Yakai Fu
    Kaiwen Wang
    Danting Zhang
    Wenwen Xu
    Zhiwei Chen
    Shuang Ye
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 293 - 304
  • [22] Case report: Successful treatment of anti-MDA5-positive to negative dermatomyositis-associated interstitial lung disease with the JAK inhibitor tofacitinib
    Jiang, Zong
    Yao, Xiaoling
    Tang, Fang
    Ma, Wukai
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (06)
  • [23] Rituximab in the treatment of anti-MDA5 dermatomyositis-associated interstitial lung disease: a case-based literature review
    Nascimento, J.
    Tenazinha, C.
    Campanilho-Marques, R.
    Cordeiro, I
    Salgado, S.
    ARP RHEUMATOLOGY, 2022, 1 (02): : 168 - 173
  • [24] MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis
    Shen, Ning
    Zhou, Xiaopeng
    Jin, Xuexiao
    Lu, Ci
    Hu, Xiuhua
    Zhang, Yichi
    Jiang, Yu
    Xu, Qin
    Xu, Xiayan
    Liu, Minghao
    Lu, Linrong
    Han, Yongmei
    RHEUMATOLOGY, 2022, 62 (01) : 373 - 383
  • [25] Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study
    Wu, Wanlong
    Xu, Wenwen
    Sun, Wenjia
    Zhang, Danting
    Zhao, Jiangfeng
    Luo, Qun
    Wang, Xiaodong
    Zhu, Feng
    Zheng, Yu
    Xue, Yu
    Wan, Weiguo
    Wu, Huaxiang
    Han, Qian
    Ye, Shuang
    RHEUMATOLOGY, 2022, 61 (01) : 230 - 239
  • [26] Plasma exchange for anti-MDA5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung disease: A case report and literature review
    Lu, Ci
    Xu, Cheng
    Zhu, Xiaoying
    Han, Yongmei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [27] Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases
    Aymonier, M.
    Abed, S.
    Boye, T.
    Barazzutti, H.
    Fournier, B.
    Morand, J. -J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (04): : 279 - 283
  • [28] Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
    Jiang, Lili
    Wang, Youlian
    Peng, Qinglin
    Shu, Xiaoming
    Wang, Guochun
    Wu, Xiaomu
    CLINICAL RHEUMATOLOGY, 2019, 38 (06) : 1655 - 1663
  • [29] Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk
    Lv, Chengyin
    You, Hanxiao
    Xu, Lingxiao
    Wang, Lei
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Zhou, Shiliang
    Da, Zhanyun
    Qian, Jie
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Wang, Yan
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Wang, Fang
    Zhang, Miaojia
    Tan, Wenfeng
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (02) : 219 - 226
  • [30] Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease
    Fujisawa, Tomoyuki
    Hozumi, Hironao
    Yasui, Hideki
    Suzuki, Yuzo
    Karayama, Masato
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 935 - 942